All In MedTech

Device Trial Radar · NCT04600791

BATwire Implant Kit Study

Last checked: Nov 19, 2026Latest source record: Oct 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registry

Status

Terminated

Enrollment

93

Actual

Start

Jan 29, 2021

Primary completion

Aug 28, 2024

Study completion Feb 17, 2025

Sponsor

Lead sponsor
CVRx, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Oct 23, 2020

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 21 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this clinical investigation is to develop valid scientific evidence for the safety and effectiveness of the Barostim System delivered by the BATwire Implant Kit (BATwire Kit) in subjects with heart failure. Subjects may be enrolled if they meet the FDA approved PMA indication for use for the Barostim NEO or Barostim NEO2 device: Subjects who remain symptomatic despite treatment with guideline-directed medical therapy, are NYHA Class III or Class II (who had a recent history of Class III), have a left ventricular ejection fraction ≤ 35%, a NT-proBNP \< 1600 pg/ml and excludes patients indicated for Cardiac Resynchronization Therapy (CRT) according to AHA/ACC/ESC guidelines.

Conditions

  • Heart Failure

Interventions

  • BATwire Implant KitDevice

    The BATwire Implant Kit is a delivery system for the placement of the Barostim Carotid Sinus Lead.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants Without Serious Adverse Events (SAEs) Related to the Implantation of the Lead Using the BATwire Implant Kit Through 30 Days Post-implant.Time frame: 30 days post-implant
  2. Change in Six Minute Hall Walk (6MHW) Distance WalkedTime frame: From baseline to 6 months of follow-up, post-implant

Locations

10 sites in 1 country. Site status is shown where the registry gives one.

  • Chan Heart Rhythm Institute

    Mesa, Arizona

  • HonorHealth

    Scottsdale, Arizona

  • AdventHealth

    Orlando, Florida

7 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.